Facilitating engagement of persons with opioid use disorder in treatment for hepatitis C virus infection via telemedicine: Stories of onsite case managers

Although hepatitis C virus (HCV) infection has high prevalence and incidence in persons with opioid use disorder (PWOUD), their engagement in HCV care has been limited due to a variety of factors. In an ongoing multisite study at 12 opioid treatment programs (OTPs) throughout New York State (NYS), we have been evaluating telemedicine accompanied by onsite administration of direct acting antiviral (DAA) medications compared with usual care including offsite referral to a liver specialist for HCV management.

Source: Journal of Substance Abuse Treatment - April 20, 2021 Category: Addiction Authors: Andrew H. Talal, Urmo Jaanim ägi, Kathleen Davis, Jordan Bailey, Barbara M. Bauer, Arpan Dharia, Saliyah George, Anthony McLeod, Karen Morton, Ann Nugent, Marija Zeremski, Amreen Dinani, Don C. Des Jarlais, Ponni V. Perumalswami, Jonathan N. Tobin, Suzan Source Type: research